Clinical Trials in Chicago

Showing 9601-9620 of 20,493 trials

An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment

NCT03335540

The purpose of this study is to evaluate the treatment of solid tumors with various immunotherapy combinations. The treatment will be determined based upon a broad biomarker assessment.

Advanced Cancer

Bristol-Myers Squibb20 participantsStarted May 2018

Chicago, Illinois, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +1 more locations

COMPLETEDPhase 1/22.2 miles

Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

NCT02024087

The purpose of this study is to evaluate the safety and tolerability of dalantercept plus sorafenib in patients with advanced hepatocellular carcinoma (HCC) to determine the recommended dose level of dalantercept in combination with sorafenib.

Advanced Adult Hepatocellular Carcinoma

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA21 participantsStarted Aug 2014

Chicago, Illinois, United States • Westwood, Kansas, United States • Boston, Massachusetts, United States +4 more locations

An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment

Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Find Trials by Condition in Chicago

Low-moderate Intensity Pedaling During Immunotherapy Administration

A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)

Pilot Study of a Novel Type of CT Scan to Assess Treatment Response During Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer

An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma

Family Supports and Beliefs Survey

A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma

A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration

A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma

Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1

Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.

Study of Denosumab in Subjects With Giant Cell Tumor of Bone

Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease

Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies.

Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma

Natural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))

Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)